WallStreetZenWallStreetZen

NYSE: ANVS
Annovis Bio Inc Stock Forecast, Predictions & Price Target

Analyst price target for ANVS

Based on 3 analysts offering 12 month price targets for Annovis Bio Inc.
Min Forecast
$9.00+1.47%
Avg Forecast
$25.00+181.85%
Max Forecast
$36.00+305.86%

Should I buy or sell ANVS stock?

Based on 3 analysts offering ratings for Annovis Bio Inc.
Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ANVS stock forecasts and price targets.

ANVS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-28
lockedlocked$00.00+00.00%2023-12-29
lockedlocked$00.00+00.00%2023-11-28

1 of 1

ANVS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANVS$8.87$25.00+181.85%Buy
MURA$5.39N/AN/A
SPRO$1.69$7.00+314.20%Buy
VINC$4.33$5.00+15.47%Strong Buy
PASG$1.69$5.00+195.86%Buy

Annovis Bio Stock Forecast FAQ

Is Annovis Bio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NYSE: ANVS) stock is to Buy ANVS stock.

Out of 3 analysts, 1 (33.33%) are recommending ANVS as a Strong Buy, 1 (33.33%) are recommending ANVS as a Buy, 1 (33.33%) are recommending ANVS as a Hold, 0 (0%) are recommending ANVS as a Sell, and 0 (0%) are recommending ANVS as a Strong Sell.

If you're new to stock investing, here's how to buy Annovis Bio stock.

What is ANVS's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ANVS price target, the average ANVS price target is $25.00, with the highest ANVS stock price forecast at $36.00 and the lowest ANVS stock price forecast at $9.00.

On average, Wall Street analysts predict that Annovis Bio's share price could reach $25.00 by Feb 28, 2025. The average Annovis Bio stock price prediction forecasts a potential upside of 181.85% from the current ANVS share price of $8.87.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.